Biopharmaceutical Manufacturing and Regulatory Affairs Certificate
The Biopharmaceutical Manufacturing and Regulatory Affairs Certificate in the School of Pharmacy at Temple University focuses on the complex regulations governing the development, manufacture and distribution of these products, preparing students for positions in biotechnology and sharpening the skills and knowledge of those already working in this field. This certificate is part of the School of Pharmacy’s regulatory affairs (RA) and quality assurance (QA) graduate program.
All courses in the Biopharmaceutical Manufacturing and Regulatory Affairs Certificate are offered online, allowing remote students to participate in this highly relevant program.
What is biopharmaceutical manufacturing?
Biopharmaceutical manufacturing uses biotechnology to develop and produce medical therapies, also known as biologics, and diagnostic processes. Ever since the first biopharmaceutical product (recombinant human insulin) was approved in 1982, products derived through biotechnology have provided medical advances that include therapeutic monoclonal antibodies, cancer vaccines, cytokines, antisense technology, interference RNA and growth factors.
Why study biopharmaceutical manufacturing in the RAQA graduate program at Temple?
The regulatory framework required for the approval of biotechnology-derived products (or biologics) is lengthy, rigorous and highly complicated. This five-course certificate presents a strong regulatory focus, enabling students to become fluent in the most current regulations and trends affecting the industry.
Learning Outcomes
- Current pharmaceutical science methods used in the discovery of biotechnology products in biopharma manufacturing, including materials sourcing and testing requirements.
- Technologies and unique considerations associated with the manufacturing and distribution of biotechnology products.
- Biotechnology regulatory affairs, such as the regulatory requirements for sterilization processes.
Career Opportunities
The biotechnology industry continues to offer new job opportunities in the U.S. and abroad. The two largest U.S. hubs for biotechnology are Boston and San Francisco, accounting for over 50,000 jobs in pharmaceutical biotechnology discovery and development. Hundreds of small, startup biotechnology companies exist throughout the U.S.
Post-master’s Certificate
Students have the option to complete a post-master’s curriculum in Biopharmaceutical Manufacturing and Regulatory Affairs. To apply for this 15-credit program, applicants must hold a master’s degree in a pharmacy-related field and a bachelor of science degree in biochemistry, biology, chemistry, physics or a health-related discipline.